Table 5.

Proportional Changes (%) in Neurocognitive Performance, Anxiety, and Depression Following the Control Trivia Questions Condition Relative to Baseline for Each Participant

Participant	Nonverbal associative learning and memory	Executive attention	Attention/language	Verbal memory	HADS-anxiety	HADS-depression
1	−13.57	0.46	15.28	−17.12	−100.00	50.00
2	7.44	7.35	38.36	12.50	−28.57	0.00
3	10.81	10.92	12.90	−1.52	−37.50	0.00
4	22.88	−0.85	10.45	29.41	0.00	0.00
5	−34.44	6.97	0.00	1.14	−33.33	0.00
6	−11.20	−5.65	20.48	1.00	−80.00	0.00
7	2.65	7.25	72.92	12.09	−58.33	16.67
8	3.70	−10.71	8.97	−7.69	33.33	0.00
9	−15.32	−10.73	0.00	0.00	−40.00	−50.00
10	−20.33	1.55	4.49	−7.69	−14.29	−40.00
11	−6.62	5.00	−7.23	−7.21	−11.11	50.00
12	−5.83	1.26	13.89	8.82	−42.86	20.00
13	−0.76	9.38	25.32	6.09	50.00	0.00
14	19.09	0.00	31.67	14.77	−33.33	−14.29
Mean	−2.96	1.58	17.68	3.19	−28.29	2.31
SD	15.64	6.90	20.25	11.85	39.64	27.61

Proportional changes on neurocognitive and emotional functioning measures are based on the following equations: GP-TQ group: (scores at 12-weeks) − (scores at baseline)/(scores at baseline) × 100; TQ-GP group: (scores at six-weeks) − (scores at baseline)/(scores at baseline) × 100. Positive values on the neurocognitive measures represent improvements in performance. Whereas negative values on the HADS represent reductions in reported symptoms.